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Abstract: The aim of this study is to
investigate the effects of PAF antagonist
BN52021 on systemic and renal oxidative
stress in experimentally induced obstructive
jaundice.
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A total of 30 Wistar-Albino type rats used in
the study were divided into sham, control and
study groups, each consisting of ten subjects.
A laparotomy was performed on the study
and control groups, and the choledochus was
ligated and dissected. In the sham group, the
choledochus was dissected by laparotomy and
not ligated. The subjects in the control group
were administered physiological saline
intraperiotoneally between the 2nd and 7th
days, and subjects in the study group were
administered BN52021 at a dose of 1
mg/kg/day. Blood and kidney samples were
taken postoperatively on the 7th day. In the
blood sample, bilirubine, SOD, GSH-PX, BUN,
creatinine determination, and in renal tissue,
MDA and histopathologic examination, were
performed.

Introduction
Acute Renal Failure (ARF) is one of the most
frequently encountered complications of obstructive
jaundice (1). In about 60-75% of subjects with
obstructive jaundice, a decrease in the Glomerule
Filtration Rate (GFR) is observed in the postoperative
period. Some 8-18% of subjects with obstructive
jaundice present acute renal failure (ARF) (2). Mortality
rate in the patients who develop renal failure is between
25 and 100% (1, 2).
The mechanism in the development of ARF in patients
with extrahepatic cholestasis is of a multi-factor type;
decrease in cardiac output, reduced peripheral
vasoconstriction, hypovolemia and elevated renal
vasoconstriction cause decreases in GFR (3). In additon,
increased prostaglandin E2, prostaglandin I2 and
thromboxane A2 are also held responsible for the
decrease in GFR (3). Biliary acids and conjugated

Serum bilirubine, blood urea nitrogen,
creatinine, renal and, within erythrocyte, MDA
levels were all measured on the 7th day in the
study and the working groups’ levels were
significantly higher than those in the sham
group. In BN52021 administered subjects,
except the billirubine parameter measured on
the 7th day, other parameters were found to
be significantly lower than in the control
group. The administration of BN52021
brought about a significant rise in the levels of
endogenous antioxidant, but it did not cause
any significant change in renal hystopathologic
scoring.
The administration of BN52021 in
experimental obstructive jaundice, improves
renal functions by increasing endogenous
antioxidant enzyme levels and by decreasing
lipid peroxidation.
Key Words: Obstructive jaundice, PAF
antagonist, renal failure, systemic stress

bilirubine result in tubular necrosis by their ischemic
effects and via direct toxic effects (4).
An increase in the levels of free oxygen radicals (FOR)
and in the levels of endogenous antioxidant enzyme play
an important role in renal malfunctions observed in
obstructive jaundice (5).
Platelet activating factor (PAF) is a phospholipid origin
mediator, which plays an important role in the tissue
damage observed in obstructive jaundice. It is formed as
a result of the activation of phospholipase A2, and has the
chemical structure of acetyl glycerol ether phosphocholine
(6). It causes vasoconstriction and permeability increase
by altering the shape of PAF endothelial cells (7).
In this study, the effects of BN52021, a PAF
antagonist, on endogenous anti-oxidant enzyme levels
and on renal functions were investigated in rats whose
extrahepatic biliary duct was ligated.
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Materials and Methods
This study was carried out in Erciyes University,
Experimental and Clinical Research Centre, upon the
approval of the Ethics Committee of the Faculty of
Medicine, Erciyes University.
Experimental Method
Male Wistar-Albino type rats, having weights between
235 and 280 g, were used in the study. The animals were
fed with standard laboratory nutrition. They were divided
into three groups, each with 10 subjects.
Intraperitoneally applied ketamine-HCl (10 mg/kg) was
used as the anaesthetic agent.
Sham Group: After administering the anaesthetic
agent, a standard midline incision laparotomy was
performed under sterile conditions, and the choledochus
was turned, but not ligated. No other substance was
given. The abdomen was closed with a two-fold suture
using 4/0 silk. On the post-operative 7th day, the rats
were given ketamine-HCl at dose of 10 mg/kg, and the
abdomen was opened from the previous incision line
under sterile conditions. A 4 ml blood sample was taken
from the heart, and both kidneys were extracted and the
animals were then sacrificed.
Control Group: After administering the anaesthetic
agent, a standard midline incision laparotomy was
performed under sterile conditions, and the choledochus
was ligated-divided, and was ligated with 6/0 silk, near
the liver hilus, and the choledochus was dissected (8). The
abdomen was closed two-fold using 4/0 suture. Between
the post-operative 2nd and 7th days physiological saline
was administered intraperitoneally. On the post-operative
7th day, the rats were given ketamine-HCl at dose of 10
mg/kg, and the abdomen was opened from the previous
incision line under sterile conditions. A 4 ml blood sample
was taken from the heart, and the two kidneys were
extracted and the animals were then sacrificed.
Study Group: They were treated in the same way as
the control group, and the choledochus was ligated to
induce obstructive jaundice. This group was administered
BN52021 (Gingolide B, BIOMOL Research Lab) at 0.2
mg/kg/day intraperitoneally on the post-operative 2nd and
7th days. On the post-operative 7th day, tissue and blood
samples were taken (9). The subject was then sacrificed.
From the blood sample taken, levels of serum
billirubin, BUN and creatinine (Cre) were measured. In
386

erythrocyte, levels of superoxide dismutase (SOD),
glutathione peroxidase (GSH-PX) and malondialdehyde
(MDA) were measured. In addition, a level of MDA in
renal tissue was measured and histopathologic
examinations were performed.
Biochemical Analysis
The blood samples taken were separated into two
separate tubes, with heparin and without heparin. GSHPX, SOD and MDA levels were measured from the blood
sample in the tube with heparin. From the blood sample
in the tube without heparine, levels of serum billirubine,
BUN and Cre were measured. The blood samples were
centrifuged at 3,000 rpm for 10 min and their sera were
separated. Remaining erythrocytes were washed three
times with 0.9% NaCl solution. The serum and washed
erythrocyte samples were stored at –70oC until the
experiment date. Total bilirubine, BUN, CRE in sera were
analysed by a Technicon RAXT automatic analyser.
GSH-PX and SOD
Erythrocyte Sample

determination

within

The erythrocyte samples previously stored at –70ºC
were allowed to dissolved in the room temperature, and
determination of glutathione peroxsidase (RANSEL, RS504, Randox) and SOD (RANSOD, SD 125, Randox) as
performed (U/g Hb).
Determination Of Lipid Peroxidation In Kidney And
Within Erythrocyte
One of the extracted kidneys was homogenised by
adding 9 ml of 1.15% KCl solution on 1 g wet tissue,
using a Bilser BH-105H model homogeniser with a Teflon
tip. Kidney and erythrocyte samples were preserved at
–70ºC until the experiment date. When making
determinations, they were dissolved at room temperature
and, using the Ohkawa Method, on 0.1 ml tissue or a
blood sample was respectively added to 0.2 ml sodium
dodecyl sulphate (SDS), 1.5 ml tiobarbituric acid (TBA)
and 1.5 ml acetic acid, and the volume of the mixture was
made up to 4 ml with distilled water. The mixture was
kept at 95ºC for an hour, and after cooling, 5 ml butanol
/ pyridine and 1 ml distilled water were added. It was
then centrifuged at 4,000 rpm, and the absorbance of the
supernatant part was measured at 532 nm, using a
Shimadzu–UV 160 A model spectrophotometer (10)
(Renal tissue MDA: nmol MDA/g wet tissue and within
erythrocyte MDA: nmol/ g Hb).
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Histopathological Evaluation
After the tissues were fixed in neutral buffer
formaline solution, they were subjected to routine tissue
procedures, and paraffin blocks were prepared. Sections
of 5-µm thickness were stained with haematoxylin–eosine
and examined under a light microscope. Findings
concerning acute renal failure were scored from 0 to 10.
Under x40 magnification, 100 tubules were counted in
10 different regions. Tubular cytoplasm vacuolisation
was scored as 0 or 1 (0 = absent, 1 = present), brush-lie
side loss as (1), flattening in tubular epithelium as (1), cell
necrosis as (1 or 2), and the means of the scores was
taken (11).
Statistical analysis
ANOVA (for Post Anova, Scheffe) test was used in the
comparison of parameters among all three groups.
Statistical calculations were performed using SPSS
Program under Windows. Values of p<0.05 were taken
as significant (12).
Findings
Total bilirubine values measured in the control and
study groups on the 7th day were found to be significantly

BUN and CRE levels measured in the control and study
groups on the 7th day were found to be significantly
higher than in the sham group (p<0.001, Table I). On the
other hand, these values were lower in the study group
than in those of the control group (p<0.05, Table I).
Renal MDA levels and MDA levels within erythrocyte
in the control and study groups were significantly higher
than the sham group, and SOD and GSH-PX levels were
significantly lower (p<0.001 or p<0.05, Table I). In
addition, renal and erythrocyte MDA levels in the study
groups were found to be significantly lower than in the
control group, while SOD and GSH-PX levels of
erythrocyte were significantly higher (p< 0.05, Table 1).
While the histologic scoring performed on the 7th day
in the control and study groups was significantly higher
when compared to the sham group, these two groups did
not have any difference between each other (p>0.05,
Table II). Histopathologic changes, especially tubular
cytoplasmic vacuolisation, were observed. Necrosis was
not seen in any of the subjects.

Sham
(X±SD)

Control
(X±SD)

Study
(X±SD)

TBIL (mg/dl)

0.62±0.1

8.10±0.4

7.1+0.2

<0.001

<0.001

>0.05

BUN (mg/dl)

21±2

65±12

34±7

<0.001

<0.001

<0.05

CRE (mg/dl)

0.5±0.1

2.1±0.2

1.1±0.2

<0.001

<0.001

<0.05

SOD (U/g Hb)

907±29

714±16

798+23

<0.001

<0.001

<0.001

GSH-PX (U/g Hb)

1321±37

781+24

901±28

<0.001

<0.001

<0.05

MDA (nmol/g Hb)

1.4±0.1

3.2±0.4

2.1±0.5

<0.001

<0.001

<0.05

Renal MDA(nmol
MDA/g wet tissue)

66±23

147±38

112±26

<0.001

<0.05

<0.05

* Comparison of sham and control groups
** Comparison of sham and study groups

Score

p*

higher than in the sham group (p<0.001, Table I).
However, there was no difference between the control
and study groups (p>0.05, Table I).

p**

Comparison
of
biochemical
changes among the groups.

Table 2.

Comparison of Histologic Scoring.

*** Comparison of control and study groups
(ANOVA Post-Hoc Sheffe test)

Sham
(X±SD)

Control
(X±SD)

Study
(X±SD)

p*

p**

p***

0±0

1.28±0.2

1.21±0.1

<0.05

<0.05

>0.05

* Comparison of sham and control groups
** Comparison of sham and study groups

Table 1.
p***

*** Comparison of control and study groups
(ANOVA Post-Hoc Sheffe test)
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Discussion
Although ARF observed in obstructive jaundice was
defined several years ago, its pathology has not been
clearly defined. However, several factors have been
separately shown to have effects. Among these factors
are, deposition of bilirubine and biliary salts into tubules,
decreased cardiac pulse, hypovolaemia arising from longterm inability of aural feeding, Tumor Necrosis Factor
(TNF), cytokines such as PAF, prosto-glandines and
endotoxemia (1-3). The secretion of urine and fractional
sodium and potassium in the presence of obstructive
jaundice increases (13).
Micro-perfusion studies have shown that biliary acids
decrease fluid absorption from proximal tubules (14).
This effect may arise from the detergent effect of biliary
acids, as well as from changes in cyclo-oxygenase (4). On
the other hand, in chronic cholestasis, biliary acids
containing sulphate, suppress the pump functions of NaK ATPase (15). It has been shown that in animals with a
ligated common biliary duct, water intake decreases by
60%, creatinine clearance and total body fluid decrease
by 15%, extracellular fluid by 24%, and plasma volume
by 15%, after 12 days (16).
PAF is a mediator playing important roles in the
formation of tissue damage and renal failure observed in
obstructive jaundice (6). Due to the effects of PAF, liver
secretes TNF; interleukin-6 while an increase is also
observed in the absorption of endotoxins (17, 18).
Renal intraarterial exogen results in a PAF infusion
decrease in GFR and the oliguria. These effects are
prevented with PAF antagonist SRI 63-675 (19). In
another study, it was observed that this PAF increase
effect depends on the dose, and that with BN52021
significant decreases are observed in GFR (20).
Endotoxin plays a significant role in renal malfunction
observed in obstructive jaundice. In an ARF model, in
which exogen endotoxin data are induced, the PAF
Antagonist BN52021 caused significant increases in GFR
(19). In post-ischemic ARF, PAF levels were found to be
significantly higher than the control group, and decreases
were observed in renal functions after the administration
of BN 52021 (9). In patients who were followed due to
renal failure caused by sepsis, PAF level was found to be
significantly high (21).
In obstructive jaundice models induced in rats, liver
PAF levels increased 6-fold after 24 hours, and reached a
peak on the 7th day. For this reason, we gave PAF
388

antagonist BN52021 to the subjects starting from the 2nd
day.
In our study, BUN and creatinine levels in the study
group were found to be significantly lower (p<0.05,
Table 1). However, no significant change was observed in
histopathologic scoring (p>0.05). This can be explained
by the antagonisation of the vasoconstriction effect of
BN52021, which has been shown in previous studies. In
the experimental obstructive jaundice study of Zhou et al.
(6), the level of tromboxane B2, a strong vasoconstrictor,
which was found to be high on the 7th day, was
significantly reduced with BN52021 and WEB1270 (6).
As a result of the passage of bilirubine and biliary salts
into systemic circulation, mitochondrial oxidative
phosphorilysis in renal tubules becomes disrupted and
causes FOR formation. Biliary salts prevent ATP
formation, and cause damage in renal lysosome and cell
membranes. This renal damage brings about results
similar to those caused by ischaemia. As a result,
decreases in glomerule hydrostatic pressure, loss of
glomerule permeability and tubular back infiltration are
observed. Increased PAF levels in obstructive jaundice and
its ischaemic effects may be held responsible for the
occurrence of these results.
Several studies have shown that FORs and lipid
peroxidase play important roles in tissue and renal
damage which occur in obstructive jaundice (5). In rats
with the common biliary duct ligated, decreases in plasma
A and vitamin E levels have been observed starting from
the 4th day of ligation (22). In the same study, decreases
in glutathione, GSH-PX and SOD levels have been
reported too. In another work, while MDA levels, which
is the final lipid peroxidation product in obstructive
jaundice, were found to be high, significant decreases
were observed in the levels of plasma glutathione, GSHPX, SOD, catalase, selenium, glutathione and glutathione
transferase (23). The occurrence of the suppression in
microsomal P-450, an important endogenous antioxidant
in obstructive jaundice, increases damage caused by
oxygen radicals (24). In a study carried out by Yuceyar et
al. (5), a temporary renal ischaemia was induced in rats
with the common biliary duct ligated, and renal
dysfunction was found to be more profound in this
group. It was shown in the same study that decreases in
the levels of SOD and GSH-PX, which are among the
antioxidant enzymes, played important roles in renal
functions (5).
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Bautista and Spitzer, in their work, showed that PAF
is a very important mediator in the formation of SOR,
and that it significantly decreased with SDZ 63-441, a
PAF antagonist (25).
In our study, the SOD and GSH-PX levels within
erythrocytes determined on the 7th day were significantly
lower in the control and study groups than in the sham
group. Treatment with BN52021 significantly increased
levels of endogenous antioxidant enzymes (Table I). Renal
MDA levels and MDA levels within erythrocyte were found
to be significantly higher in rats with induced obstructive
jaundice than in the sham group (Table I).

In conclusion, the administration of BN52021 in
experimental obstructive jaundice improved renal
functions by increasing levels of antioxidant enzymes and
by decreasing levels of systemic and renal MDA.
Correspondence author:
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